Stay updated with breaking news from Nasdaq Amph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 1,860,000 shares, a growth of 29.2% from the April 15th total of 1,440,000 shares. Approximately 5.3% of the company’s stock are sold short. Based […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) was the target of a large growth in short interest in April. As of April 30th, there was short interest totalling 1,860,000 shares, a growth of 29.2% from the April 15th total of 1,440,000 shares. Currently, 5.3% of the shares of the stock are short sold. Based on […]
Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) were up 8.9% on Wednesday . The company traded as high as $39.87 and last traded at $39.70. Approximately 317,490 shares traded hands during mid-day trading, an increase of 3% from the average daily volume of 309,719 shares. The stock had previously closed at $36.44. Wall […]
SG Americas Securities LLC lifted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 138.8% during the 4th quarter, HoldingsChannel reports. The fund owned 10,588 shares of the company’s stock after purchasing an additional 6,154 shares during the period. SG Americas Securities LLC’s holdings in Amphastar Pharmaceuticals were worth $297,000 at […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) was the target of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 1,310,000 shares, a drop of 10.3% from the March 15th total of 1,460,000 shares. Based on an average trading volume of 286,100 shares, the […]